GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Sec16b | decreases expression | EXP | | 6480464 | CTD | bisphenol A results in decreased expression of SEC16B mRNA | PMID:30816183 | Sec16b | increases expression | EXP | | 6480464 | CTD | bisphenol A results in increased expression of SEC16B mRNA | PMID:25181051 | Sec16b | affects splicing | ISO | Sec16b (Mus musculus) | 6480464 | CTD | bisphenol A affects the splicing of SEC16B mRNA | PMID:37894381 | Sec16b | decreases expression | ISO | Sec16b (Mus musculus) | 6480464 | CTD | bisphenol A results in decreased expression of SEC16B mRNA | PMID:32156529 | Sec16b | decreases methylation | ISO | SEC16B (Homo sapiens) | 6480464 | CTD | bisphenol A results in decreased methylation of SEC16B gene | PMID:31601247 | Sec16b | multiple interactions | ISO | SEC16B (Homo sapiens) | 6480464 | CTD | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SEC16B mRNA | PMID:28628672 | |
Go Back to source page | Continue to Ontology report |